Age-related reference intervals for bone turnover markers from an Australian reference population

Bone ◽  
2013 ◽  
Vol 55 (2) ◽  
pp. 271-276 ◽  
Author(s):  
N. Jenkins ◽  
M. Black ◽  
E. Paul ◽  
J.A. Pasco ◽  
M.A. Kotowicz ◽  
...  
2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Sandhya Nair ◽  
Sonam Hatkar ◽  
Anushree Patil ◽  
Suchitra Surve ◽  
Beena Joshi ◽  
...  

Author(s):  
Emma T Callegari ◽  
Alexandra Gorelik ◽  
Suzanne M Garland ◽  
Cherie Y Chiang ◽  
John D Wark

Background The use of bone turnover markers in clinical practice and research in younger people is limited by the lack of normative data and understanding of common causes of variation in bone turnover marker values in this demographic. To appropriately interpret bone turnover markers, robust reference intervals specific to age, development and sex are necessary. This study aimed to determine reference intervals of bone turnover markers in females aged 16–25 years participating in the Safe-D study. Methods Participants were recruited through social networking site Facebook and were asked to complete an extensive, online questionnaire and attend a site visit. Participants were tested for serum carboxy-terminal cross-linking telopeptide of type 1 collagen and total procollagen type 1 N-propeptide using the Roche Elecsys automated analyser. Reference intervals were determined using the 2.5th to 97.5th percentiles of normalized bone turnover marker values. Results Of 406 participants, 149 were excluded due to medical conditions or medication use (except hormonal contraception) which may affect bone metabolism. In the remaining 257 participants, the reference interval was 230–1000 ng/L for serum carboxy-terminal cross-linking telopeptide of type 1 collagen and 27–131  µg/L for procollagen type 1 N-propeptide. Both marker concentrations were inversely correlated with age and oral contraceptive pill use. Therefore, intervals specific to these variables were calculated. Conclusions We defined robust reference intervals for cross-linking telopeptide of type 1 collagen and procollagen type 1 N-propeptide in young females grouped by age and contraceptive pill use. We examined bone turnover markers’ relationship with several lifestyle, clinical and demographic factors. Our normative intervals should aid interpretation of bone turnover markers in young females particularly in those aged 16 to 19 years where reference intervals are currently provisional.


Bone ◽  
2012 ◽  
Vol 50 (5) ◽  
pp. 1141-1147 ◽  
Author(s):  
Richard Eastell ◽  
Patrick Garnero ◽  
Christine Audebert ◽  
David L. Cahall

2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Wei-Wei Hu ◽  
Zeng Zhang ◽  
Jin-Wei He ◽  
Wen-Zhen Fu ◽  
Chun Wang ◽  
...  

The reference ranges of bone turnover markers (BTMs) were important during the treatment of osteoporosis, and the associations with bone mineral density (BMD) were controversial. The aim of this study was to establish the reference ranges of N-terminal procollagen of type l collagen (P1NP), osteocalcin (OC), and beta C-terminal cross-linked telopeptides of type I collagen (β-CTX) in Shanghai area and to investigate the relationships between BTMs and BMD in postmenopausal women. 2,799 subjects recruited in Shanghai City were measured BTMs to establish the reference ranges. Additional 520 healthy postmenopausal women were also measured BTMs, these women measured BMD in addition. BTMs were measured using the Roche electrochemiluminescence system. We used the age range of 35 to 45-year-olds to calculate reference intervals. The reference range of OC was 4.91 to 13.90 ng/mL for women and 5.58 to 16.57 ng/mL for men, P1NP was 13.72 to 32.90 ng/mL for women and 16.89 to 42.43 ng/mL for men, andβ-CTX was 0.112 to 0.210 ng/mL for women and 0.100 to 0.378 ng/mL for men. BTMs significantly negatively correlated with lumbar spine and femoral and total hip in postmenopausal women ( = −0.157~−0.217,P< 0.001). We established the normal reference ranges of P1NP, OC, andβ-CTX in the Shanghai area. This study also found that BTMs correlated with BMD and suggested that BTMs were the key determining factors of early BMD decreases.


2014 ◽  
Vol 73 (Suppl 2) ◽  
pp. 769.1-769
Author(s):  
N. Guañabens ◽  
X. Filella ◽  
A. Monegal ◽  
C. Gomez-Vaquero ◽  
M. Bonet ◽  
...  

2014 ◽  
Vol 14 (1) ◽  
Author(s):  
Xi-Yu Wu ◽  
Hong-Li Li ◽  
Hui Xie ◽  
Xiang-Hang Luo ◽  
Yi-Qun Peng ◽  
...  

Bone ◽  
2013 ◽  
Vol 57 (2) ◽  
pp. 399-404 ◽  
Author(s):  
J. Michelsen ◽  
H. Wallaschofski ◽  
N. Friedrich ◽  
C. Spielhagen ◽  
R. Rettig ◽  
...  

2014 ◽  
Author(s):  
Nuria Guanabens ◽  
◽  
Xavier Filella ◽  
Ana Monegal ◽  
Carmen Gomez-Vaquero ◽  
...  

2015 ◽  
Vol 100 (1) ◽  
pp. 90-99 ◽  
Author(s):  
S. A. Paul Chubb ◽  
Elizabeth Byrnes ◽  
Laurens Manning ◽  
John P. Beilby ◽  
Peter R. Ebeling ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document